Medtronic Q1 Beats Estimates; Guidance Affirmed

By | September 3, 2015

Scalper1 News

Medical-device giant Medtronic (MDT) beat analysts’ quarterly estimates and affirmed its guidance Thursday, sending its stock up as much as 1.3% in early trading. Medtronic reported fiscal Q1 earnings, excluding one-time items, of $1.02 a share in the quarter ended July 31, up 3% from the year-earlier quarter and a penny over views. Revenue totaled $7.27 billion, up 70% from last year’s Q1, or 12% if you include the recently acquired Covidien in Scalper1 News

Scalper1 News